{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:21:21Z","timestamp":1787653281799,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"DOI":"10.7759\/cureus.59113","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T05:55:06Z","timestamp":1714197306000},"source":"Crossref","is-referenced-by-count":5,"title":["Salivary and Serum Interleukin-6: A Credible Marker for Predicting Oral Leukoplakia and Oral Squamous Cell Carcinoma by Enzyme-Linked Immunosorbent Assay (ELISA)"],"prefix":"10.7759","author":[{"given":"Mary","family":"Oshin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan  G","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Prasad Reddy","family":"D","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Deepthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthi Sai","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jishnu K","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sintl.2020.100046","article-title":"Oral cancer diagnosis and perspectives in India","volume":"1","author":"Borse V","year":"2020","unstructured":"Borse V, Konwar AN, Buragohain P. Oral cancer diagnosis and perspectives in India. Sens Int. 2020, 1:100046. 10.1016\/j.sintl.2020.100046","journal-title":"Sens Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2016.17.11.4899","article-title":"Salivary and serum interleukin-6 levels in oral premalignant disorders and squamous cell carcinoma: diagnostic value and clinicopathologic correlations","volume":"17","author":"Dineshkumar T","year":"2016","unstructured":"Dineshkumar T, Ashwini BK, Rameshkumar A, Rajashree P, Ramya R, Rajkumar K. Salivary and serum interleukin-6 levels in oral premalignant disorders and squamous cell carcinoma: diagnostic value and clinicopathologic correlations. Asian Pac J Cancer Prev. 2016, 17:4899-906. 10.22034\/APJCP.2016.17.11.4899","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.3390\/app10113896","article-title":"Tobacco, alcohol and family history of cancer as risk factors of oral squamous cell carcinoma: case-control retrospective study","volume":"10","author":"Tenore G","year":"2020","unstructured":"Tenore G, Nuvoli A, Mohsen A, et al.. Tobacco, alcohol and family history of cancer as risk factors of oral squamous cell carcinoma: case-control retrospective study. Appl Sci. 2020, 10:3896.","journal-title":"Appl Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.134651","article-title":"Epidemiology, control and prevention of tobacco induced oral mucosal lesions in India","volume":"51","author":"Sridharan G","year":"2014","unstructured":"Sridharan G. Epidemiology, control and prevention of tobacco induced oral mucosal lesions in India. Indian J Cancer. 2014, 51:80-5. 10.4103\/0019-509X.134651","journal-title":"Indian J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jobcr.2015.11.002","article-title":"Clinico-epidemiological study of oral squamous cell carcinoma: a tertiary care centre study in North India","volume":"6","author":"Singh MP","year":"2016","unstructured":"Singh MP, Kumar V, Agarwal A, Kumar R, Bhatt ML, Misra S. Clinico-epidemiological study of oral squamous cell carcinoma: a tertiary care centre study in North India. J Oral Biol Craniofac Res. 2016, 6:31-4. 10.1016\/j.jobcr.2015.11.002","journal-title":"J Oral Biol Craniofac Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany S","year":"2019","unstructured":"Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019, 20:10.3390\/ijms20236008","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4309485","article-title":"Cytokines as biomarkers and their respective clinical cutoff levels","volume":"2017","author":"Monastero RN","year":"2017","unstructured":"Monastero RN, Pentyala S. Cytokines as biomarkers and their respective clinical cutoff levels. Int J Inflam. 2017, 2017:4309485. 10.1155\/2017\/4309485","journal-title":"Int J Inflam"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23615","article-title":"Interleukin-6 predicts recurrence and survival among head and neck cancer patients","volume":"113","author":"Duffy SA","year":"2008","unstructured":"Duffy SA, Taylor JM, Terrell JE, et al.. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer. 2008, 113:750-7. 10.1002\/cncr.23615","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari N","year":"2016","unstructured":"Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016, 37:11553-72. 10.1007\/s13277-016-5098-7","journal-title":"Tumour Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller J","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011, 1813:878-88. 10.1016\/j.bbamcr.2011.01.034","journal-title":"Biochim Biophys Acta"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S125620","article-title":"Biomarkers in traumatic brain injury (TBI): a review","volume":"14","author":"Dadas A","year":"2018","unstructured":"Dadas A, Washington J, Diaz-Arrastia R, Janigro D. Biomarkers in traumatic brain injury (TBI): a review. Neuropsychiatr Dis Treat. 2018, 14:2989-3000. 10.2147\/NDT.S125620","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-021-00131-7","article-title":"Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma","volume":"13","author":"Elmusrati A","year":"2021","unstructured":"Elmusrati A, Wang J, Wang CY. Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. Int J Oral Sci. 2021, 13:24. 10.1038\/s41368-021-00131-7","journal-title":"Int J Oral Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2014.01.008","article-title":"The two faces of IL-6 in the tumor microenvironment","volume":"26","author":"Fisher DT","year":"2014","unstructured":"Fisher DT, Appenheimer MM, Evans SS. The two faces of IL-6 in the tumor microenvironment. Semin Immunol. 2014, 26:38-47. 10.1016\/j.smim.2014.01.008","journal-title":"Semin Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano T","year":"2021","unstructured":"Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021, 33:127-48. 10.1093\/intimm\/dxaa078","journal-title":"Int Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2209\/tdcpublication.48.199","article-title":"Comparison of salivary cytokine levels in oral cancer patients and healthy subjects","volume":"48","author":"Katakura A","year":"2007","unstructured":"Katakura A, Kamiyama I, Takano N, et al.. Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll. 2007, 48:199-203. 10.2209\/tdcpublication.48.199","journal-title":"Bull Tokyo Dent Coll"},{"key":"ref16","article-title":"Salivary concentration of TNF alpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma","volume":"13","author":"Sahebjamee M","year":"2008","unstructured":"Sahebjamee M, Eslami M, Atarbashi-Moghadam F, Sarafnejad A. Salivary concentration of TNF alpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma. Medicina Oral Patologia Oral y Cirugia Bucal. 2008, 13:292-5.","journal-title":"Medicina Oral Patologia Oral y Cirugia Bucal"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.17323","article-title":"Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer","volume":"17","author":"Brailo V","year":"2012","unstructured":"Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A, Balija M. Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal. 2012, 17:e10-5. 10.4317\/medoral.17323","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref18","article-title":"Serum and salivary levels of proinflammatory cytokines as potential biomarkers in the diagnosis of oral squamous cell carcinoma","volume":"21","author":"Hamad AW","year":"2009","unstructured":"Hamad AW. Serum and salivary levels of proinflammatory cytokines as potential biomarkers in the diagnosis of oral squamous cell carcinoma. J Bagh College Dentistry . 2009, 21:60-5.","journal-title":"J Bagh College Dentistry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7150\/jca.5112","article-title":"The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas","volume":"4","author":"Koontongkaew S","year":"2013","unstructured":"Koontongkaew S. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J Cancer. 2013, 4:66-83. 10.7150\/jca.5112","journal-title":"J Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223698","article-title":"The role of IL-6 in cancer cell invasiveness and metastasis-overview and therapeutic opportunities","volume":"11","author":"Ra\u0161kov\u00e1 M","year":"2022","unstructured":"Ra\u0161kov\u00e1 M, Lacina L, Kej\u00edk Z, et al.. The role of IL-6 in cancer cell invasiveness and metastasis-overview and therapeutic opportunities. Cells. 2022, 11:3698. 10.3390\/cells11223698","journal-title":"Cells"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones SA","year":"2018","unstructured":"Jones SA, Jenkins BJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol. 2018, 18:773-89. 10.1038\/s41577-018-0066-7","journal-title":"Nat Rev Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter CA","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015, 16:448-57. 10.1038\/ni.3153","journal-title":"Nat Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson DE","year":"2018","unstructured":"Johnson DE, O'Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018, 15:234-48. 10.1038\/nrclinonc.2018.8","journal-title":"Nat Rev Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2014.03.003","article-title":"Tumor microenvironment in head and neck squamous cell carcinoma","volume":"41","author":"Curry JM","year":"2014","unstructured":"Curry JM, Sprandio J, Cognetti D, Luginbuhl A, Bar-ad V, Pribitkin E, Tuluc M. Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol. 2014, 41:217-34. 10.1053\/j.seminoncol.2014.03.003","journal-title":"Semin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1793","article-title":"Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells","volume":"32","author":"Krishnamurthy S","year":"2014","unstructured":"Krishnamurthy S, Warner KA, Dong Z, et al.. Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells. Stem Cells. 2014, 32:2845-57. 10.1002\/stem.1793","journal-title":"Stem Cells"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/242020-salivary-and-serum-interleukin-6-a-credible-marker-for-predicting-oral-leukoplakia-and-oral-squamous-cell-carcinoma-by-enzyme-linked-immunosorbent-assay-elisa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T05:55:13Z","timestamp":1714197313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/242020-salivary-and-serum-interleukin-6-a-credible-marker-for-predicting-oral-leukoplakia-and-oral-squamous-cell-carcinoma-by-enzyme-linked-immunosorbent-assay-elisa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.59113","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}